The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
Biocon | biocon stock | Stake sale
The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
BENGALURU (Reuters) - Indian biopharma company Biocon sold a 9.96% stake in its unit and contract research firm Syngene International through open market sale, it said in an exchange filing on Wednesday.
With the sale, the total promoter stake of Biocon in Syngene stands at 54.6%, the exchange filing showed.
Biocon did not reveal the price at which the stake was sold.
Officials at Syngene and Biocon did not immediately respond to a Reuters query seeking the reason for the stake sale and the price at which the sale was executed.
Biocon was selling the stake in Syngene to fund the acquisition of Viatris Inc's biosimilars business that it announced last year, CNBC TV-18 reported on Tuesday.
The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said.
Biocon Biologics had in February 2022 said it would buy the U.S. drug maker's biosimilars business in a deal valued at $3.34 billion.
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing.
Biocon's shares closed up 2%, while those of Syngene added 0.74% on Wednesday.
(Reporting by Nallur Sethuraman in Bengaluru; Editing by Dhanya Ann Thoppil)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, February 01 2023. 19:33 IST
JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more
Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more
The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more
In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more
The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more
The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more